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Abstract
Background: The indigenous gut microbiota are thought to play a crucial role in the development and maintenance
of the abnormal inflammatory responses that are the hallmark of inflammatory bowel disease. Direct tests of the role of
the gut microbiome in these disorders are typically limited by the fact that sampling of the microbiota generally occurs
once disease has become manifest. This limitation could potentially be circumvented by studying patients who
undergo total proctocolectomy with ileal pouch anal anastomosis (IPAA) for the definitive treatment of ulcerative
colitis. A subset of patients who undergo IPAA develops an inflammatory condition known as pouchitis, which is
thought to mirror the pathogenesis of ulcerative colitis. Following the development of the microbiome of the pouch
would allow characterization of the microbial community that predates the development of overt disease.
Results: We monitored the development of the pouch microbiota in four patients who underwent IPAA. Mucosal and
luminal samples were obtained prior to takedown of the diverting ileostomy and compared to samples obtained 2, 4
and 8 weeks after intestinal continuity had been restored. Through the combined analysis of 16S rRNA-encoding gene
amplicons, targeted 16S amplification and microbial cultivation, we observed major changes in structure and function
of the pouch microbiota following ileostomy. There is a relative increase in anaerobic microorganisms with the
capacity for fermentation of complex carbohydrates, which corresponds to the physical stasis of intestinal contents in
the ileal pouch. Compared to the microbiome structure encountered in the colonic mucosa of healthy individuals, the
pouch microbial community in three of the four individuals was quite distinct. In the fourth patient, a community that
was much like that seen in a healthy colon was established, and this patient also had the most benign clinical course
of the four patients, without the development of pouchitis 2 years after IPAA.
Conclusions: The microbiota that inhabit the ileal-anal pouch of patients who undergo IPAA for treatment of
ulcerative colitis demonstrate significant structural and functional changes related to the restoration of fecal flow. Our
preliminary results suggest once the pouch has assumed the physiologic role previously played by the intact colon, the
precise structure and function of the pouch microbiome, relative to a normal colonic microbiota, will determine if
there is establishment of a stable, healthy mucosal environment or the reinitiation of the pathogenic cascade that
results in intestinal inflammation.
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Background
The inflammatory bowel diseases (IBD) are a heteroge-
neous group of chronic, relapsing ailments of unknown
origin that afflict over a million people in the US. There
are two major forms of IBD. Crohn’s disease is an in-
flammatory disorder that can involve any part of the
gastrointestinal tract, but more often involves the ileo-
cecal region. Ulcerative colitis (UC), on the other hand,
only involves the colon and, almost without exception,
extends from the rectum proximally in a continuous
manner. The singular localization of these diseases sug-
gests that topical or regional factors are important in
their development. In this regard, indigenous enteric mi-
crobes may play an important role, particularly as they
have been strongly implicated in the etiopathogenesis of
inflammatory bowel diseases [1-4].
The search for typical bacterial pathogens for the eti-
ology of IBD has not been particularly fruitful. More
recently, the concept that specific communities of mi-
crobes play a key role in the pathogenesis of IBD has
been aided by the use of culture-independent surveys of
microbial community structure [5]. A growing number
of studies have demonstrated that patients with IBD
often have altered communities of enteric microbes or
“dysbiosis” [6-8]. However, a key limitation is that these
studies are generally cross sectional in design, and while
associations between IBD and dysbiosis may be robust,
the case for actual causation is often much weaker.
Pouchitis is an inflammatory condition of the sur-
gically created pseudorectum reservoir that develops
within 1 year in over half of UC patients who under-
go total colectomy with ileal pouch anal anastomosis
(IPAA) [9,10]. The condition is relatively unique to UC,
as non-IBD patients (e.g., those with familial adenoma-
tous polyposis) who undergo the same surgical proce-
dure rarely develop pouchitis [11]. Temporal analysis of
the microbiome in patients who undergo IPAA can be
accomplished in a manageable timeframe with few con-
founding variables, and patients can serve as their own
controls. These unique characteristics of IPAA in the
setting of UC permit longitudinal monitoring of the mi-
crobes in the gut prior to the development of disease in
a setting with a relatively high incidence of pathology.
In this study, we monitored the development of the
pouch microbiota in a group of UC patients who under-
went colectomy with IPAA. Starting from a time just
prior to the takedown of the diverting ileostomy, we
noted the transition of the pouch microbial community
between multiple structural states, many of which are
still distinct from the structural and functional charac-
teristics of a healthy colonic microbiota. The driver for
these changes appears to be the restoration of the flow
of intestinal contents to the pouch and of the conversion
of the distal ileum to a reservoir where fecal stasis oc-
curs. It remains to be determined if the ultimate matur-
ation of the pouch microbiome to one that resembles
that seen in the healthy colon prevents the eventual de-
velopment of pouchitis.
Methods
Study design and patients
In this study, four patients (Table 1) with a history of
UC undergoing total abdominal colectomy with IPAA
(Figure 1) were identified from the outpatient and in-
patient practices of gastroenterologists and colorectal
surgeons at the University of Chicago Medical Center
between 2010 and 2011. All four patients had a con-
firmed diagnosis of ulcerative colitis based on endoscopy
and pathology findings, were scheduled for a total proc-
tocolectomy with ileal pouch anal anastomosis, and were
willing and able to participate in the study. Exclusion
criteria included pregnancy or inability to give informed
consent. All patients gave written informed consent be-
fore screening. The Institutional Review Board of the
University of Chicago Medical Center approved this
study protocol. Mucosal biopsy samples were also col-
lected from the colons of healthy individuals to serve as
a comparison group (Table 1). These samples were
Table 1 Patient demographics
Patient Age
(y)
Sex Disease duration at colectomy
(years)
Reason for
colectomy
Extent of colonic
inflammation
Tobacco
use
Family history of
IBD
200 23 Male 2 Medically refractory Extensive Never No
206 19 Male 1 Medically refractory Extensive Never No
207 31 Male 2 Fulminant Extensive Ex-smoker No
210 45 Male <1 Medically refractory Extensive Ex-smoker No
300 29 Female Control n/a n/a n/a Never No
302 27 Female Control n/a n/a n/a Never No
303 23 Male Control n/a n/a n/a Never No
304 25 Female Control n/a n/a n/a Never No
305 25 Male Control n/a n/a n/a Current No
Young et al. Microbiome 2013, 1:9 Page 2 of 11
http://www.microbiomejournal.com/content/1/1/9
obtained without prior bowel preparation to ensure that
the microbiota were not altered by this procedure.
Healthy controls were otherwise healthy, and colonos-
copies were performed solely for research purposes.
Healthy subject 304 was on oral contraceptives at the
time of colonoscopy. The other healthy controls were on
no medication at the time of colonoscopy.
The study design was as follows. The date of ileostomy
takedown was considered as the reference point for com-
parison of subsequent samples. One to 2 weeks prior to
takedown of the patient’s loop ileostomy, a pouchoscopy
was performed (visit 1; Figure 1). Mucosal biopsies and
brushings of the ileal pouch were obtained, and a stool
aspirate was collected. Two weeks, 4 weeks, and 2 months
(visits 2, 3, 4; Figure 1) after the takedown of the ileos-
tomy, pouchoscopy was performed with collection of mu-
cosal biopsies, mucosal brushings and stool aspirate. The
Pouch Disease Activity Index (PDAI [12]) was calculated
at each visit.
Mucosal biopsies using standard biopsy forceps were
obtained from the sigmoid healthy control patients,
throughout the colon and from the ileal pouch in pa-
tients with ileal pouches. Mucosal brushings were also
obtained in our study population (patients with ileal
pouches). Cytology brushes were advanced through the
endoscope, and mucosal brushings were obtained with
the intent to cover a large surface area with each brush.
The cytology brush was then covered in a sterile sheath
prior to being removed from the endoscope. Patient 200
was on 5 mg of prednisone for 1 week following ostomy
takedown. Patient 210 was on a low dose of prednisone
following ostomy takedown (5 mg daily), which was
slowly tapered off by visit 4. The other two patients were
on no medications during the study visits.
Sample collection and processing
Biopsy and brush samples were collected during the
endoscopy, stored accordingly depending upon the down-
stream workflow, placed on dry ice at the time of collec-
tion (apart from those targeted for histology) and archived
at −80°C thereafter. Storage conditions according to work-
flow were as follows: biopsies targeted for bulk DNA ex-
traction were placed in Fecal Dry Bead Tubes (MO BIO
Laboratories, Inc.), and brushes targeted for microbial cul-
tivation were stored in cryovials containing 1× anaerobic
GBSS buffer (supplement material) supplemented with
DMSO (5% final concentration). Bulk DNA was extracted
from biopsies using a modified protocol for the Roche
MagNA Pure System incorporating mechanical disruption
(bead beating) as described previously [13].
Amplicon library construction
Replicate amplicon libraries for bacterial 16S v3 through
v5 regions (Bv3v5) were constructed from all samples.
The adapter and 16S rRNA-encoding gene-specific se-
quences are shown in Table 2. Each primer contains ei-
ther the A or B 454 Titanium amplicon adapter followed
by a 5-nt multiplex identifier (MID; barcode) and ends
with the 16S specific sequence. Bv3v5 amplicons were
generated using a pool of two forward and three reverse
primers, and the MID is present in all five oligonucleo-
tides. All MIDs differ by at least two bases and contain
no homopolymers.
Figure 1 Anatomy of ileal pouch anal anastomosis (IPAA). Patients who undergo a two-stage IPAA procedure initially undergo a total
colectomy with the construction of the ileal pouch, which is anastomosed to the rectum. Diversion of the fecal stream occurs through an
ileostomy. Study subjects were initially sampled at this stage (visit 1) with specimens harvested from the diverted pouch. In the second stage of
the IPAA procedure, the diverting ileostomy is taken down and continuity is restored to the ileum, restoring the flow of intestinal contents to the
ileal pouch. The subsequent samples were obtained from the ileal pouch, which was accessed via the rectum (visits 2, 3 and 4). Control samples
were obtained from healthy individuals who had the same anatomy as the IPAA subjects prior to the first stage of the procedure.
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Both primer sets were designed to capture over 95% of
known eubacterial diversity. They match 16S genes from
50 to 100% of the members of all known phyla in our
reference database based on the SILVA 106 release [14]
with the exception of a few small phyla such as OP11
and SR1, which were not expected to be encountered in
gut communities.
The individual oligos were mixed in equal proportions
to create F/R primer pools. 16S rRNA-encoding gene
amplicons were generated by polymerase chain reaction
containing 1X Platinum HiFi Taq polymerase buffer, 1.6
units Platinum HiFi polymerase (Invitrogen/LifeTechno-
logies), 3.7 mM MgSO4, 200 uM dNTPs (PurePeak po-
lymerization mix, Pierce/ThermoFisher) and 50 nM
combined primers. Between 5–25 ng of sample DNA was
added to a master mix to a final volume of 100 ul, and this
was divided into three replicate 33-ul reactions. Cycling
conditions included an initial denaturation at 94°C for
3 min; 30 cycles of 94°C for 30 s; 60°C for 45 s, 72°C for
1 min; and a final extension at 72°C for 2 min using
an Applied Biosystems 2720 or 9700 cycler. The three
replicates were pooled and analyzed on a Bioanalyzer
DNA1000 chip. Reactions were cleaned and products
under 300 base pairs removed using Ampure beads at
0.75× volume (Agilent Technologies). The final products
were resuspended in 100 ul of 10 mM Tris-EDTA, quanti-
tated using PicoGreen Quant-IT assay (Invitrogen/
LifeTechnologies) and assayed again on a DNA1000 chip.
454 Sequencing and data analysis
Up to 40 amplicon libraries were pooled prior to emul-
sion PCR. The emPCR, enrichment and sequencing were
done according to current Roche Titanium amplicon se-
quencing protocols (Lib-A emPCR reagents, XLR se-
quencing reagents, two region PicoTitre plate). A typical
sequencing run generated an average of 80,000 tags per
sample (Additional file 1: Table S1). Image processing
and signal calling are done using the Roche amplicon
processing pipeline (version 2.5.3) with recursive phase
correction algorithm.
Pyrosequencing reads were quality-filtered by remov-
ing reads that did not have exact matches to the MID
and the proximal primer (341 F); that contained an
ambiguous base (N); that lacked a conserved distal an-
chor region used for trimming; or that had an average
quality score less than 30 [15]. The v3v5 anchor is
50-GGATTAGNTACCC-3 (position 785 F in E. coli).
Reads were trimmed after anchor sequence. Chimeras
were removed using UChime [16], combining both the
de novo and reference database (ChimeraSlayer GOLD)
modes. Taxonomy was assigned using GAST [17] and
the data uploaded to the Visualization and Analysis of
Microbial Population Structures website (VAMPS:
http://vamps.mbl.edu) for analysis. OTU clustering was
performed using UClust [18] using 97% sequence iden-
tity. All trimmed and filtered sequence tag data and tax-
onomy are available on VAMPS under the project name
prefixes HMP_200, HMP_206, HMP_207, HMP_210
and HMP_300 and have been submitted to NCBI’s se-
quence read archive (SRA) with the project ID http://www.
ncbi.nlm.nih.gov/bioproject/46315. The 16S PCoA analyses
were performed using the Morisita-Horn, Yue-Clayton and
UniFrac inter-community distance metrics at both full sam-
pling depth and with each data set subsampled to 8,461 se-
quences (the smallest data set size). All PCoAs were
virtually identical.
Cultivation from brush samples
Brush samples were frozen in 1 ml of GBSS (glucose-free
buffered salt solution, recipe at http://microbiomes.msu.
edu/resources/) buffer (with 5% dimethyl sulfoxide) until
processing. Samples were thawed on ice and vortexed for
30 s. The brush was removed and vortexed for 30 s in a
second tube with GBSS buffer, then the brush was discar-
ded. The suspended samples were combined, homogenized
by vortexing for an additional 60 s before aliquots were re-
moved for microscopy and cultivation.
Viable cell counts were obtained through plating of
serial dilutions. Triplicate dilution series for each sample
(10-fold for anoxic cultivation, 4-fold for oxic cultiva-
tion) were performed in GBSS buffer on ice in the same
environment used for downstream cultivation, followed
by plating onto complex media containing various car-
bon, nitrogen and sulfate sources common in the human
GI tract (http://microbiomes.msu.edu/resources/). Plates
were incubated at 37°C for as many as 7 days in anoxic
(2–3% H2, 5% CO2, N2) or oxic (ambient, 21% O2) atmo-
spheres. The total number of colony-forming units
(CFUs) at day 5 was used to compare viable cell density
(CFU/ml) for all samples.
To determine the overall density of microorganisms
present in the sample, direct cell counts were performed.
Samples were fixed in 3.7% formaldehyde overnight
Table 2 Primers for amplification of variable regions of
the 16S rRNA-encoding gene
Primer domain Sequence, 50 to 30
“A” adapter CGTATCGCCTCCCTCGCGCCATCAG
“B” adapter CTATGCGCCTTGCCAGCCCGCTCAG
341 F2 CCTACGGGNGGCWGCAG
341 F3 TCTACGGAAGGCTGCAG
926R1 CCGTCAATTCNTTTRAGT
926R3 CCGTCAATTTCTTTGAGT
926R4 CCGTCTATTCCTTTGANT
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at 4°C and treated with DNase I (0.5 U/μl, Roche,
Indianapolis, IN) at 37°C for 1 h, followed by mixing
with 0.1 M hydrogen chloride (1:1, v/v). Further dilu-
tions were made as necessary in 0.1 M hydrogen chlo-
ride; 4 μl of the treated sample was loaded into the
counting chamber (Hawksley Helber Bacteria 1 Cell
Thoma, Sussex, UK). Microbes deposited in nine grids
(200 μm × 200 μm/grid) were counted for each of tripli-
cate samples load. The average number of cells was used
to estimate total cell counts in the original sample. Re-
peated measures ANOVA was performed to test the
statistical significance of changes in direct or viable cell
counts over sampling time points. A linear regression
model was applied for log-transformed direct cell counts
to estimate microbial population doubling time.
Screening for butyrate producing taxa
The 16S data were harvested for known butyrate pro-
ducers of the human colon (based on [19]) at the genus
level, except for the functionally diverse Clostridia where
species discrimination was applied (Additional file 1:
Table S2). Additional butyrate-producing candidates were
revealed in luminal aspirate samples by the functional gene
targeting approach presented in the companion manu-
script Vital et al. [20] and were included in the analysis. All
results were normalized to five 16S rRNA-encoding
gene copy numbers, which represent the average for
Firmicutes and Bacteroidetes, the two most abundant phyla
in the gut. Candidates were divided into two groups
based on whether they have butyrate kinase (buk) or
butyryl-CoA:acetate CoA-transferase (but) genes, the final
genes of the two main microbial butyrate synthesis path-
ways, to facilitate data comparison with the results from
the companion manuscript.
Results
Temporal shifts in the pouch microbiome following
ileostomy takedown
Changes in the pouch mucosal microbiota after resto-
ration of the fecal stream with the ileal pouch were
monitored by sampling before and after takedown of the
diverting ileostomy (Figure 1). Amplicons targeting the
V4-6 region of the 16S rRNA-encoding gene were gene-
rated and subjected to multiplex pyrosequencing. Ana-
lysis of the 16S pyrotag data by ordination revealed that
ileostomy takedown was associated with a shift in the
composition of the pouch mucosal bacterial community.
In all four patients the most dramatic change in commu-
nity structure was seen comparing the sample obtained
prior to ileostomy takedown to the samples following re-
storative surgery (Figure 2). Less variation was seen in
the community structure among the three samples
obtained after ileostomy takedown. In accordance with
previous studies of the gut microbiota, each subject pos-
sessed a unique community of organisms when the
pyrotags were classified at all taxonomic levels (phylum
to genus) (see Figure 3, Additional file 1: Table S3 for
family level taxonomy, other levels not shown). At the
phylum level, the majority of the pyrotags were affiliated
with members of the Firmicutes and Bacteroidetes, in
particular after the ileostomy takedown.
As a comparison, we obtained samples from the co-
lonic mucosa of healthy subjects without inflammatory
bowel disease via colonoscopy. When these samples
were subjected to 16S pyrotag analysis and compared to
the pouch mucosa samples, three of the four samples
obtained prior to ileostomy takedown clustered as one
group, one patient clustered alone, and samples from
normal colonic mucosa clustered separately (Figure 2).
The samples obtained from the pouch following ileos-
tomy takedown appeared to show an intermediate com-
munity structure, although one subject (patient 210)
developed a community that fell within the community
structures encompassed by the normal colonic samples.
We compared the overall diversity of the mucosal
communities at each time point by calculating the Shan-
non index (Figure 4). For three of the subjects, there was
an increase in overall diversity following ileostomy take-
down, but in the fourth subject (patient 206), this
increase was not seen, although the community compo-
sition did change substantially. By the time the third and
fourth samples were taken, for two of the patients (200
and 210), the overall diversity was in the range of that
seen in the control colon mucosa samples.
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Figure 2 Shift in mucosal microbiota of the pouch after
takedown of diverting ileostomy in patients who had
undergone ileal pouch anal anastomosis visualized by principle
coordinates analysis of the Unifrac metric based on V3-5 16S
rRNA-encoding gene amplicons. The initial time point, prior to
takedown of the ileostomy, is indicated by the larger symbols and
subsequent time points at the end of the arrows. For comparison,
colon mucosal biopsies from healthy individuals are included on
the ordination.
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Cultivation of mucosal samples demonstrates a shift from
facultative to obligate anaerobes following ileostomy
takedown
We also tracked the development of pouch microbiota
by direct and viable cell counts. The overall density of
microorganisms in the pouch mucosa continuously in-
creased by approximately two orders of magnitude dur-
ing the sampling time series (Figure 5, p = 0.003). More
interestingly, the increase was modeled as exponential
(adjusted R2 = 0.73-0.88) over the whole sampling
period, suggesting an active proliferation of the micro-
bial community after ileostomy takedown. Model regres-
sion led to an estimated doubling time of 9 to 16 days
for the pouch microbiota over the sampling time. By the
last sampling point, which was 2 months after ileostomy
takedown, the overall microbial cell density in all three
patients was still at least one order of magnitude lower
than that in healthy colon mucosa samples.
Mucosal samples obtained with a cytology brush were
cultured under anoxic and oxic atmospheres to examine
the response of the microbial communities to oxygen.
The numbers of both anaerobic and aerobic cultivars
increases rapidly after ileostomy takedown and then
declines gradually 4 weeks later. The anaerobic counts
are always higher than the aerobic counts. More interes-
tingly, the ratio of the two viable counts (shown as the
vertical distance between anaerobic and aerobic counts
at the same time point in Figure 5) increased from 1.6 to
more than 20 over time following ileostomy takedown.
It suggests a shift from facultative to more obligate
anaerobes of the pouch microbiota. In contrast, healthy
colons had similar levels of anaerobic counts, but two to
three orders of magnitude lower aerobic cell densities
compared to the pouch samples.
Shifts in diversity correlated with an increase in potential
butyrate metabolism following ileostomy takedown
The 16S pyrotag data and the cultivation data document
significant changes in the community inhabiting the
pouch mucosa following ileostomy takedown. To deter-
mine if these changes in community structure were as-
sociated with potential functional changes, we analyzed
the 16S rRNA gene data from biopsy samples at the
genus and species level for butyrate-producing candi-
dates (Figure 6). Few potential butyrate-producing bac-
teria were detected at the time of the initial visit (visit 1;
except for patient 206, who exhibited a considerable
Peptoniphilus community), whereas abundant communi-
ties with this potential were established in all patients
shortly after ileostomy takedown (visit 2) and remained
consistent during the remaining two sampling points.
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Figure 4 Change in diversity of the mucosal microbial
communities inhabiting the ileal/anal pouch of patients after
ileostomy takedown. The Shannon diversity index was calculated
for each community based on OTUs defined at sequence
divergence ≥ 0.03.
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Figure 3 Taxonomic classification of V3-5 16S rRNA-encoding
gene amplicon sequences from patients who had undergone
ileal pouch anal anastomosis. The relative abundance of major
phylotypes, classified to the level of family and grouped by phylum,
is indicated. Time point 1 is prior to ileostomy takedown, and time
points 2, 3 and 4 are 2, 4 and 8 weeks after takedown.
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Profiles were distinct, however, between individuals with
abundant buk-carrying candidates (mainly Clostridium
butyricum and C. perfringens) in patients 206 and 207,
whereas species associated with but were dominant in
patients 200 and 210. Only patient 210 exhibited both
Faecalibacterium sp. and Roseburia sp., which are con-
sidered to be among the most abundant butyrate pro-
ducers in the healthy colon [19] (as also observed in our
control samples). Additional but-linked bacteria, namely
Acidaminococcus sp. and Coprococcus sp., were present
at high concentrations in several samples.
Discussion
In this study we describe the establishment of the enteric
microbial community in the ileal pouch of patients with
a history of UC who have undergone total colectomy with
IPAA. Our study is unique in examining the relationship
of the microbiota and pouchitis and offers several advan-
tages: (1) a clearly defined starting point when all patients
are free of disease and off medications, (2) the opportunity
to observe the development of a nascent pouch micro-
biota relative to the maturation of the ileal pouch, (3) sam-
pling of mucosa-associated pouch microbiota without
colonic lavage [21] and (4) the identification of pouch mi-
crobial communities that may be associated with health or
increased risk of disease.
We were able to determine that in all four patients the
pouch microbial community evolved over time, but it did
so in a manner that was unique to each individual. As
expected, the shift in the microbial community in each in-
dividual was most evident immediately after closure of the
diverting ileostomy and reinstitution of the fecal stream
through the pouch. While the microbial communities
continued to evolve over time, the changes were less pro-
nounced. The microbial community appeared to move
toward a more “healthy” colonic community at each sub-
sequent visit in patients 206, 207 and 210. However, in pa-
tient 200, while the microbial community initially moved
toward a “healthy” colonic community, it drifted away
from the healthy colonic community structure 1 and 2
months after ileostomy closure. Interestingly, this patient
whose microbial community was less similar over time to
the communities of the healthy colons developed chronic
pouchitis 7 months after visit 4 and was diagnosed with C.
difficile of the ileal pouch 10 months following visit 4. Pa-
tients 206 and 207 both had episodes of acute pouchitis at
16 and 17 months, respectively, following closure of the
ileostomy. Both patients responded well to antibiotic treat-
ment. Patient 210’s microbial community structure moved
closest to the community structure observed in healthy
colon samples, and this patient has had the best clinical
outcome of the four subjects. Two years into the study, he
continues to do well with no episodes of pouchitis.
Although our sample size was small, our findings sug-
gest that the failure to develop a mature microbial com-
munity similar to that found in the healthy colon in the
months following ostomy closure increases susceptibi-
lity to pouchitis. Alternatively, if an individual’s pouch
microbiota develop into a diverse, mature community
similar to that found in the healthy colon, we propose
the risk of pouchitis is decreased. Falk and colleagues
also performed a longitudinal study in two patients with
a history of UC undergoing colectomy with IPAA [22].
They followed these two patients for 1 year after sto
ma closure. Although the microbial profiles were quite
different between the two patients, both individuals’
mucosal-associated microbiota evolved over time and
became more “colon-like.” Neither patient developed
pouchitis.
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Figure 5 Changes in the direct counts and viable cell density
from pouch mucosal samples. Brush samples obtained during
endoscopy were loaded onto a counting chamber for direct cell
counts (A). Error bars were standard errors of three counts per
sample. Anaerobic and aerobic cultivation on complex medium was
performed. The number of colony-forming units (CFU) on day 5 was
used to calculate viable cell density (CFU/ml) (B). Error bars were
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the figure.
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Others have compared the pouch microbiota in patients
with and without pouchitis, although the results from
these various studies have varied, and no clear association
between particular bacterial profiles has been identified
[23-26]. Komanduri et al. pooled mucosal samples from
patients with UC healthy pouch, UC pouchitis and non-
IBD controls. They described shifts in the microflora
(dysbiosis) in patients with pouchitis, with an increase in
the proportion of Fusobacter (phylum Proteobacteria) and
a decrease in Streptococci (phylum Firmicutes). In another
Pe
rc
en
ta
ge
 o
f b
ut
yr
at
e 
co
m
m
un
ity
1     2     3      4
Patient
200
1     2     3
Controls
buk but
Pe
rc
en
ta
ge
 o
f t
ot
al
 c
om
m
un
ity ? ?
?
0.001
0.01
0.1
1
10
100
0
20
40
60
80
100
Faecalibacterium sp.
Roseburia sp.
Eubacterium sp.
Coprococcus sp.
Acidaminococcus sp.
Anaerostipes sp.
Oscillibacter sp.
Peptoniphilus sp.
Megasphaera sp.
C. butyricum
C. perfringens
Anaerotruncus sp.
Subdoligranulum sp.
Enterococcus sp.
1     2     3      4
Patient
206
1     2     3      4
Patient
207
1     2     3      4
Patient
2 01
A
B
Figure 6 Analysis of 16S rRNA-encoding gene data for butyrate-producing communities. Panel A shows the cumulative result of obtained
candidates associated with butyryl-CoA:acetate CoA-transferase (but; grey bar) and butyrate kinase (buk; white stripped bar). Below (B) individual
compositions of communities are given. Results are corrected for multiple 16S rRNA-encoding gene copy numbers for individual bacteria. ? =
butyrate production was shown for one strain of Subdoligranulum sp. as it is unclear whether all members of this genus have the potential to
synthesize butyrate.
Young et al. Microbiome 2013, 1:9 Page 8 of 11
http://www.microbiomejournal.com/content/1/1/9
study examining the mucosal-associated microbiota from
ileal pouches, diversity was greater in the UC patients
without pouchitis compared to the UC patients with
pouchitis. There were no specific phylotypes associated
with pouchitis [23].
Dysbiosis of the intestinal microbiota is commonly
found in patients with IBD [27], but in almost all cases,
the question remains as to whether these changes are
causes or consequences of the activated immune and in-
flammatory condition. Typically, large changes in 16S
rRNA gene-based profiles are observed at the phylum
level, characterized by blooms of Proteobacteria and
changes in the relative abundance of Firmicutes and
Bacteroidetes [28]. Significant differences in the func-
tional metagenomes of enteric microbes from healthy
and IBD patients have also been shown [29]. However,
the observed structural and functional changes are not
unique to human IBD and can be found in other non-
IBD inflammatory states [30,31] and in experimental col-
itis [32-34], suggesting that these changes are largely a
consequence of the altered immune and inflammatory
state. These large, descriptive data sets have shed little
light on fundamental mechanisms of IBD etiopatho-
genesis and are often confounded by difficult to control
variables inherent to clinical studies, including diffe-
rences in individual microbiomes, medication (including
antibiotics), diet, genetics, and environmental and life-
style factors.
Several studies have suggested that the overall diversity
of the gut microbiota is decreased in the setting of IBD.
However, our results indicate that diversity in and of it-
self (as measured by a metric such as the Shannon diver-
sity) is not necessarily a predictor of disease. While it is
true that patients 210 and 200 both developed pouch
mucosal communities that were similar in overall diver-
sity to that seen in the normal colon, patient 200 de-
veloped severe, refractory pouchitis, while patient 210
remains healthy after 2 years of follow-up. Rather than
using overall diversity as a measure of “health” of the
microbiome, it is likely that the specific composition and
thus function of the community are the key predictors.
In this regard, the community in patient 210 is most
similar in composition and structure to that seen in the
healthy colon, while the community in patient 200 is
quite distinct, despite having relatively high overall di-
versity. This is also reflected in the relative potential of
the communities to produce the beneficial SCFA buty-
rate where the community in patient 210 had a much
higher potential of butyrogenesis compared to that in
patient 200.
The importance of specific microbial functions is fur-
ther indicated in our analysis of the butyrogenic poten-
tial of an individual patient’s microbiome. Abundant
butyrate-producing communities were established in all
patients after ileostomy takedown, but only patient 210
exhibited both taxa Roseburia sp. and Faecalibacterium sp.
(Figure 6), which are considered to be the main butyrate
producers in healthy colons [19,20]. In our companion
work (Microbiome, submitted in parallel to this manu-
script), we specifically investigated the diversity (via a
pyrosequencing strategy) and abundance (via quantitative
PCR) of butyrate-producing genes in corresponding lu-
minal samples taken at the same time as mucosa samples.
All patients established an abundant butyrate-producing
community (approximately 5–26% of the total commu-
nity) after ileostomy takedown, but with distinct profiles
between patients, where patient 210 was the only individ-
ual exhibiting a but/k profile similar to those of the control
samples. Whereas the overall patterns between 16S rRNA
gene analysis (of luminal samples) and the functional
gene-targeted approach were consistent, only the latter
could reveal butyrate-producing gene families and their
inferred taxa in detail to more directly evaluate the
butyrogenic potential. Unfortunately, it was not possible to
use the functional gene-targeted approach in this mucosal
study because of the low amount of bacterial DNA in most
biopsy samples. However, 16S rRNA gene patterns specific
for butyrate producers from Vital et al. [20] were identical
to results presented here (Figure 6), suggesting consistency
in functional gene profiles between mucosa and luminal
derived samples as well. Indeed, we were able to retrieve
qPCR data from mucosal samples of patient 210 (only visit
3 and 4) and found but genes linked to Roseburia sp./Eu-
bacterium sp. and F. prausnitzii (data not shown) at abun-
dances similar to luminal aspirates and consistent with the
16S rRNA gene data presented in Figure 6. The observed
progression of patient 210 toward a “healthy type” bacter-
ial community based on global 16S rRNA analysis was
consistent with the development of a specific butyrate-
producing community similar to that of healthy colons.
The question of how individual bacterial profiles relate to
the actual production of butyrate and whether abnormal
communities perform equally compared to regular ones is
under study.
This study describes the establishment of the pouch
microbiota in a longitudinal manner. This is the first step
toward understanding how the intestinal microbiota influ-
ence or trigger the development of the inflammatory res-
ponse seen in IBD. Despite our small sample size, we can
confirm that there is an evolution of the microbial com-
munity in all individuals. These changes were apparent
when the communities were followed by multiple meth-
odologies. This includes the use of culture-independent
surveys based on retrieval of 16S rRNA-encoding gene se-
quences, specific culture-based techniques and targeted
analysis of functional genes.
Structurally and functionally, we find that the mucosal
microbial community of the pouch moves toward a com-
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munity more similar to a colonic microbial community
following ileostomy takedown. Nonetheless, the member-
ship within the community is distinct from the colonic
microbial community, likely secondary to the influence of
the small intestinal epithelium on the development of the
pouch microbiota and the overall anatomic differences
inherent to IPAA. The establishment of a pouch micro-
biota similar to a healthy colonic microbial community is
potentially protective against pouchitis. In the future, lon-
gitudinal studies, such as this one, may provide the oppor-
tunity to identify patterns of the microbial community,
both in terms of structure and function, that predict the
onset of inflammation or disease in at-risk individuals.
Conclusions
The results of this study demonstrate a marked shift in
the structure and function of the microbiota that inhabit
the mucosa of patients who have ileal-anal pouch anas-
tomosis for ulcerative colitis. This shift is characterized
by a transition to a community that is selected for fer-
mentation, preferentially a beneficial one such as buty-
rate production. It is likely that the community structure
and function of the pouch microbiome will influence the
likelihood of the development of pouchitis, with the de-
velopment of a pouch microbiome that resembles that
seen in the normal colon being protective against the de-
velopment of disease. Monitoring of the development of
the pouch microbiome may be able to predict which pa-
tients require more aggressive monitoring for the de-
velopment of pouchitis and potential early treatment/
prevention using modalities designed to shift the micro-
biota into a more normal community.
Supporting data
The data sets supporting the results of this article are
available in the VAMPS repository (http://vamps.mbl.edu),
which is supported by NSF grant NSF DBI-0960626 to S.
Huse.
Additional file
Additional file 1: Counts for pyrosequencing tags in study.
Table S2 Butyrate-producing candidates searched for in the 16S rRNA
gene data and their corresponding gene copy numbers based on rrnDB
(http://rrndb.mmg.msu.edu) and IMG (http://img.jgi.doe.gov). Table S3
Taxonomic composition for pouch communities at four time points
(companion data for Figure 3).
Abbreviations
IPAA: ileal pouch anal anastomosis; IBD: inflammatory bowel diseases;
UC: ulcerative colitis; PDAI: pouch disease activity index; MID: multiplex
identifier; buk: butyrate kinase; but: butyryl-CoA:acetate CoA transferase.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
VY contributed to the study design, coordinated the various study sites and
drafted the manuscript. SG and JV performed amplicon sequencing under
the direction of HM. AE, PS, SH, HM and MS analyzed the 16S amplicon data
and contributed to writing the manuscript. JB, NH, LR and SD were involved
in the acquisition, processing and analysis of mucosal samples, and JK and
GR performed the endoscopic procedures. LR also contributed to the study
design and writing the manuscript. RA recruited and schedule all the
patients, maintains the patient metadata and performed patient follow-up.
MV and JT designed and performed the functional gene analysis and
contributed to drafting the manuscript. DA contributed to the study design,
set up a tracking system for coordination and distribution of samples with
JB, and contributed to writing the manuscript with FM. DD cultivated and
characterized bacteria from the pouch. TS oversaw the cultivation portion of
the project and contributed to the writing of the manuscript. EC conceived
the overall study design with VY, MS, JT, TS and FM, assisted with the writing
of the manuscript and analysis of data, and created the infrastructure at U of
C for this program. All authors read and approved the final manuscript.
Acknowledgements
The main funding for the work came from an NIH Human Microbiome
Project Demonstration Project Award (UH2/3 DK083993) to VY, GC, TS, MS,
FM and JT. Additional funding for elements of the work came from P30
DK42086 and the Leona M. and Harry B. Helmsley Foundation to EC, R01
HG005975 to PDS, and a Crohn’s and Colitis Foundation of America Award to LR.
Author details
1Department of Internal Medicine, Division of Infectious Diseases, Ann Arbor,
MI, USA. 2Department of Microbiology and Immunology, University of
Michigan Medical School, Ann Arbor, MI, USA. 3Department of Internal
Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic,
Rochester, MN, USA. 4Josephine Bay Paul Center, Marine Biological
Laboratory, Woods Hole, MA, USA. 5Center for Microbial Ecology, Michigan
State University, East Lansing, MI, USA. 6Department of Microbiology and
Molecular Genetics, Michigan State University, East Lansing, MI, USA.
7Institute for Genomics and Systems Biology, Argonne National Laboratory,
Argonne, IL, USA. 8Department of Medicine, Section of Gastroenterology, The
University of Chicago, Knapp Center for Biomedical Discovery, Chicago, IL,
USA.
Received: 30 August 2012 Accepted: 10 January 2013
Published: 4 March 2013
References
1. Sartor RB: Microbial influences in inflammatory bowel diseases.
Gastroenterology 2008, 134(2):577–594.
2. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory
bowel disease. Nature 2007, 448(7152):427–434.
3. Eckburg PB, Relman DA: The role of microbes in Crohn’s disease.
Clin Infect Dis 2007, 44(2):256–262.
4. Nagalingam NA, Lynch SV: Role of the microbiota in inflammatory bowel
diseases. Inflamm Bowel Dis 2012, 18(5):968–984.
5. Young VB, Kahn SA, Schmidt TM, Chang EB: Studying the enteric
microbiome in inflammatory bowel diseases: getting through the
growing pains and moving forward. Front Microbiol 2011, 2:144.
6. Lepage P, Hasler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S,
Kupcinskas L, Dore J, Raedler A, et al: Twin study indicates loss of
interaction between microbiota and mucosa of patients with ulcerative
colitis. Gastroenterology 2011, 141(1):227–236.
7. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Jarnerot
G, Tysk C, Jansson JK, Engstrand L: A pyrosequencing study in twins shows
that gastrointestinal microbial profiles vary with inflammatory bowel
disease phenotypes. Gastroenterology 2010, 139(6):1844–1854. e1841.
8. Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G,
Ciulla D, Tabbaa D, Ingram J, et al: Non-invasive mapping of the
gastrointestinal microbiota identifies children with inflammatory bowel
disease. PLoS One 2012, 7(6):e39242.
9. Pardi DS, Sandborn WJ: Systematic review: the management of pouchitis.
Alimentary pharmacology & therapeutics 2006, 23(8):1087–1096.
Young et al. Microbiome 2013, 1:9 Page 10 of 11
http://www.microbiomejournal.com/content/1/1/9
10. Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH: J ileal pouch-anal
anastomosis for chronic ulcerative colitis: complications and long-term
outcome in 1310 patients. The British journal of surgery 1998, 85(6):800–803.
11. Salemans JM, Nagengast FM, Lubbers EJ, Kuijpers JH: Postoperative and
long-term results of ileal pouch-anal anastomosis for ulcerative colitis
and familial polyposis coli. Digestive diseases and sciences 1992,
37(12):1882–1889.
12. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF: Pouchitis
after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.
Mayo Clin Proc 1994, 69(5):409–415.
13. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB: The
interplay between microbiome dynamics and pathogen dynamics in a
murine model of Clostridium difficile Infection. Gut Microbes 2011,
2(3):145–158.
14. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, Glockner FO:
SILVA: a comprehensive online resource for quality checked and aligned
ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res
2007, 35(21):7188–7196.
15. Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM: Accuracy and
quality of massively parallel DNA pyrosequencing. Genome biology 2007,
8(7):R143.
16. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R: UCHIME improves
sensitivity and speed of chimera detection. Bioinformatics 2011,
27(16):2194–2200.
17. Huse SM, Dethlefsen L, Huber JA, Welch DM, Relman DA, Sogin ML:
Exploring microbial diversity and taxonomy using SSU rRNA
hypervariable tag sequencing. PLoS Genet 2008, 4(11):e1000255.
18. Edgar RC: Search and clustering orders of magnitude faster than BLAST.
Bioinformatics 2010, 26(19):2460–2461.
19. Louis P, Flint HJ: Diversity, metabolism and microbial ecology of butyrate-
producing bacteria from the human large intestine. FEMS Microbiol Lett
2009, 294(1):1–8.
20. Vital M, Penton CR, Wang Q, Young VB, Antonopoulos DA, Sogin ML,
Morrison HG, Raffals L, Chang EB, Huffnagle GB, Schmidt TM, Cole JR, Tiedje
JM: A gene-targeted approach to investigate the intestinal butyrate-
producing bacterial community. Microbiome 2013, 1:8.
21. Raffals LH: Understanding the Pouch Microbiota, Digestive diseases and
sciences: an Evolving Story; 2012.
22. Falk A, Olsson C, Ahrne S, Molin G, Adawi D, Jeppsson B: Ileal pelvic pouch
microbiota from two former ulcerative colitis patients, analysed by DNA-
based methods, were unstable over time and showed the presence of
Clostridium perfringens. Scandinavian journal of gastroenterology 2007,
42(8):973–985.
23. McLaughlin SD, Walker AW, Churcher C, Clark SK, Tekkis PP, Johnson MW,
Parkhill J, Ciclitira PJ, Dougan G, Nicholls RJ, et al: The bacteriology of
pouchitis: a molecular phylogenetic analysis using 16S rRNA gene
cloning and sequencing. Annals of surgery 2010, 252(1):90–98.
24. Komanduri S, Gillevet PM, Sikaroodi M, Mutlu E, Keshavarzian A: Dysbiosis in
pouchitis: evidence of unique microfloral patterns in pouch
inflammation. Clinical gastroenterology and hepatology: the official clinical
practice journal of the American Gastroenterological Association 2007,
5(3):352–360.
25. Johnson MW, Rogers GB, Bruce KD, Lilley AK, von Herbay A, Forbes A,
Ciclitira PJ, Nicholls RJ: Bacterial community diversity in cultures derived
from healthy and inflamed ileal pouches after restorative
proctocolectomy. Inflamm Bowel Dis 2009, 15(12):1803–1811.
26. Lim M, Adams JD, Wilcox M, Finan P, Sagar P, Burke D: An assessment of
bacterial dysbiosis in pouchitis using terminal restriction fragment
length polymorphisms of 16S ribosomal DNA from pouch effluent
microbiota. Diseases of the colon and rectum 2009, 52(8):1492–1500.
27. Peterson DA, Frank DN, Pace NR, Gordon JI: Metagenomic approaches for
defining the pathogenesis of inflammatory bowel diseases. Cell Host
Microbe 2008, 3(6):417–427.
28. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR:
Molecular-phylogenetic characterization of microbial community
imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U
S A 2007, 104(34):13780–13785.
29. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L,
Nalin R, Jarrin C, Chardon P, Marteau P, et al: Reduced diversity of faecal
microbiota in Crohn’s disease revealed by a metagenomic approach. Gut
2006, 55(2):205–211.
30. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC,
Finlay BB: Host-mediated inflammation disrupts the intestinal microbiota
and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe
2007, 2(2):119–129.
31. Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB:
Antibiotic-induced perturbations of the intestinal microbiota alter host
susceptibility to enteric infection. Infect Immun 2008, 76(10):4726–4736.
32. Nagalingam NA, Kao JY, Young VB: Microbial ecology of the murine gut
associated with the development of dextran sodium sulfate-induced
colitis. Inflamm Bowel Dis 2011, 17(4):917–926.
33. McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, Liu Z, Lozupone CA,
Hamady M, Knight R, Bushman FD: The macaque gut microbiome in
health, lentiviral infection, and chronic enterocolitis. PLoS Pathog 2008,
4(2):e20.
34. Hoffmann C, Hill DA, Minkah N, Kirn T, Troy A, Artis D, Bushman F:
Community-wide response of the gut microbiota to enteropathogenic
Citrobacter rodentium infection revealed by deep sequencing. Infect
Immun 2009, 77(10):4668–4678.
doi:10.1186/2049-2618-1-9
Cite this article as: Young et al.: Multiphasic analysis of the temporal
development of the distal gut microbiota in patients following ileal
pouch anal anastomosis. Microbiome 2013 1:9.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Young et al. Microbiome 2013, 1:9 Page 11 of 11
http://www.microbiomejournal.com/content/1/1/9
